NRS 2002: Nutritional Screen in Cancer Patients

Sponsor
Sociedad de Lucha Contra el Cáncer del Ecuador (Other)
Overall Status
Completed
CT.gov ID
NCT04137666
Collaborator
(none)
68
1
4
17

Study Details

Study Description

Brief Summary

Diagnosing the nutritional status of cancer patients is extremely important. An appropriate nutritional status supports a better tolerance to the treatment. A working protocol is essential to start with Nutritional Screening. If it is detected Malnutrition Risk or Malnutrition, diet counseling, and the specific therapeutic for each patient must be provided.

This descriptive study will serve three aims:
  • Register in the cancer patient's electronic medical record their nutritional status at the admission and when the patient is discharged.

  • Determine the percentage of malnourished patients or in the risk of malnutrition who are admitted to hospitalization.

  • Recognize the number of patients that required specialized nutritional care.

The purpose of this study is to determine if 30% of the patients admitted to the headquarters of SOLCA in Guayaquil from the Ecuadorian Cancer Society are at malnutrition risk or with any specific malnutrition level.

Detailed Description

A prospective, descriptive, non-interventional study that will be performed from July 1st to October 4th of 2019 in all hospitalized patients of the Internal Medicine Service from SOLCA in Guayaquil from the Ecuadorian Cancer Society.

Statistical analysis: Central tendency measures. The results will be presented with tables and graphs.

Two weeks before the start of the study, the training of the personnel that will intervene in the screening of the participants will be carried out and will have a flow chart of actions to follow according to the status of patients.

Study Design

Study Type:
Observational
Actual Enrollment :
68 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
NRS 2002: Nutritional Screen in Cancer Patients
Actual Study Start Date :
Jun 1, 2019
Actual Primary Completion Date :
Oct 1, 2019
Actual Study Completion Date :
Oct 1, 2019

Outcome Measures

Primary Outcome Measures

  1. Nutritional Status [60 days]

    Registration in the cancer patients' Clinical Record their nutritional status when they are admitted and when they are discharged

  2. Percentage of malnourished patients or at risk of malnourishment [60 days]

    To know the percentage of malnourished patients or at risk of malnourishment that are admitted for hospitalization

  3. Patients who needed specialized nutritional care [60 days]

    Recognize the number of patients who needed specialized nutritional care

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participants older than 18-year old that go to the mentioned service
Exclusion Criteria:
  • All patients with more than 48 hours of hospital admission

  • Pediatric population.

  • Patients with edema, non-malignant conditions (family of SOLCA workers) or with oncologic diagnosis not confirmed

  • Participants who use a wheelchair or stretcher and those who cannot stand up

The NRS 2002 screening tool will be used to collect data and register the electronic medical record of each patient according to their nutritional status.

The variables to be recorded in an online Excel shared sheet (Google Drive) are weight, height, BMI, age, cancer diagnosis, associated comorbidities.

For weight determination, a scale (mechanical or electronic) in good condition will be used

Contacts and Locations

Locations

Site City State Country Postal Code
1 Instituto Oncológico Nacional Dr. Juan Tanca Marengo Guayaquil Guayas Ecuador 090505

Sponsors and Collaborators

  • Sociedad de Lucha Contra el Cáncer del Ecuador

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sociedad de Lucha Contra el Cáncer del Ecuador
ClinicalTrials.gov Identifier:
NCT04137666
Other Study ID Numbers:
  • CISOLGYE20190020
First Posted:
Oct 24, 2019
Last Update Posted:
Oct 24, 2019
Last Verified:
Oct 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sociedad de Lucha Contra el Cáncer del Ecuador
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 24, 2019